Table 3. Test for equality of survival distributions for different levels of gene expression in each risk factor group and different stage group.

Gene name	Protein name	p-value	stage	Test	Median survival
					Low expression	High expression
SLC2A1	GLUT1	0.0062**	I & II	Log rank	83.18	55.68
SLC2A2	GLUT2	0.0050**	I & II	Gehan-breslow-Wilcoxon	45.89	83.18
SLC2A1	GLUT1	0.0264*	III & IV	Gehan-breslow-Wilcoxon	30.58	18.27
SLC2A2	GLUT2	0.0025**	III & IV	Gehan-breslow-Wilcoxon	17.97	39.75
Gene name	Protein name	Risk factor	p-value	Test	Median survival (months)
					Low expression	High expression
SLC2A2	GLUT2	Alcohol consumption (O)	0.1675	Gehan-breslow-Wilcoxon	30.58	102.66
		Alcohol consumption (X)	< 0.001***	Gehan-breslow-Wilcoxon	41.75	80.68
		Hepatitis B (O)	0.0131*	Log rank	NA	NA
		Hepatitis B (X)	0.0083**	Gehan-breslow-Wilcoxon	30.58	70.01
		Hepatitis C (O)	0.1483	Gehan-breslow-Wilcoxon	25.23	60.84
		Hepatitis C (X)	< 0.001***	Gehan-breslow-Wilcoxon	45.07	83.18